Browse Studies — Arctuva

Phase 1

Advancing Personalized Treatment in Pediatric Oncology Through Functional Precision Medicine

Functional precision medicine (FPM) is a relatively new approach to cancer therapy based on direct exposure of patient- isolated tumor cells to clinically appr…

Recurrent Childhood Acute Myeloid LeukemiaRecurrent Childhood Acute Lymphoblastic LeukemiaRecurrent Childhood Large Cell Lymphoma+15 more

Estimated

~$10 – $6,250

Florida International UniversityNCT05857969

Phase 2

Lead-In and Phase II Study of Clofarabine, Etoposide, Cyclophosphamide [CEC], Liposomal Vincristine (VCR), Dexamethasone and Bortezomib in Relapsed/Refractory Acute Lymphoblastic Leukemia (ALL) and Lymphoblastic Lymphoma (LL)

This phase II trial studies the side effects and how well combination chemotherapy works in treating patients with acute lymphoblastic leukemia, lymphoblastic …

Recurrent Acute Lymphoblastic LeukemiaRecurrent Adult Lymphoblastic LymphomaRecurrent Burkitt Leukemia+8 more

Estimated

~$10 – $6,250

M.D. Anderson Cancer Center

Exploring the Effect of Calaspargase Pegol on the Coagulation System in Pediatric Acute Lymphoblastic Leukemia (ALL) Patients: Pilot Study

This study evaluates the impact of calaspargase pegol (Cal-PEG) on the coagulation system in pediatric patients with acute lymphoblastic leukemia/lymphoma (ALL…

Childhood Acute Lymphoblastic LeukemiaChildhood Lymphoblastic Lymphoma

Estimated

~$10 – $750

Mayo ClinicNCT07071051

Evaluation of Prolonged Asparaginase Activity Levels After Calaspargase Pegol Administration

This study evaluates the median duration of therapeutic serum asparaginase activity (SAA) levels after administration of calaspargase pegol (Cal-PEG) and the p…

Childhood Acute Lymphoblastic LeukemiaChildhood Lymphoblastic Lymphoma

Estimated

~$10 – $750

Mayo ClinicNCT07221656